HEART CONDUCTION AND RHYTHM DISORDERS IN IKTAL EPILEPSY PERIOD: THE PREVALENCE AND PREDICTORS

Aim. To assess the characteristics and prevalence of cardiac rhythm disorders in epilepsy patients during the iktal period, by long term ECG monitoring.

Material and methods. To the study, 79 patients included, age 18 to 51 y. o. with confirmed diagnosis of focal epilepsy with continuing attacks regardless the antiepilepsy treatment. For rhythm disorder screening, all patients underwent implanting of subcutaneous ECG monitors.

Results. Disorders of cardiac rhythm and conduction during the iktal period were found in 88,61% cases. Most prevalent were sinus tachycardia (59,5%, 47 cases), cardiac rhythm and conduction disorders (29%, 23 cases). In 9 cases (11,4%) there were no cardiac rhythm and conduction disorders registered. Also, the probable predictors found, of the disorders of cardiac rhythm in epilepsy patients. Patients gender, type of attacks, frequency, circadian specifics were the markers influencing the rate of iktal cardiac rhythm changes.

Conclusion. Sinus tachycardia, rhythm and conduction disorders are registered in most of patients during the iktal period and significantly more common in males, the patients with bilateral tonic and clonic seizures, serial course of the attacks and in the patients with sleep-related seizures. Evaluation of antiepilepsy treatment influence on the prevalence of iktal rhythm and conduction disorders did not reveal significant difference for none of the drug groups. Also, there was no significant differences in comparison of the studied parameters for polyand monotherapy by anticonvulsants.

1. Duncan S., Brodie M. J. Sudden unexpected death in epilepsy. Epilepsy Behav. 2011;21(4):344-51. doi:10.1016/j.yebeh.2011.04.056.

2. Rugg-Gunn FJ, Simister RJ, Squirrell M, et al. Cardiac arrhythmias in focal epilepsy: a prospective long-term study. Lancet. 2004;364(9452):2212-9. doi:10.1016/S01406736(04)17594-6.

3. Bermeo-Ovalle AC, Kennedy JD, Schuele SU. Cardiac and autonomic mechanisms contributing to SUDEP. J Clin Neurophysiol. 2015;32(1):21-9. doi:10.1097/WNP.0000000000000155.

4. Surges R, Sander JW. Sudden unexpected death in epilepsy: Mechanisms, prevalence, and prevention. Curr Opin Neurol. 2012;25(2):201–7. doi:10.1097/WCO.0b013e3283506714.

5. Aurlien D, Gjerstad L, Tauboll E. The role of antiepileptic drugs in sudden unexpected death in epilepsy. Seizure. 2016;43: 56-60. doi:10.1016/j.seizure.2016.11.005.

6. Avakyan GN, Blinov DV, Lebedeva AV, et al. ILAE Classification of the epilepsies: the 2017 revision and update. Epilepsia and paroxyzmal conditions. 2017;9(1):6-25. (In Russ.)

7. Ravindran K, Powell KL, Todaro M, et al. The pathophysiology of cardiac dysfunction in epilepsy. Epilepsy Res. 2016;127:19-29. doi:10.1016/j.eplepsyres.2016.08.007.

8. Shmuely S, Van der Lende M, Lamberts RJ, et al. The heart of epilepsy: Current views and future concepts. Seizure. 2017;44:176-83. doi:10.1016/j.seizure.2016.10.001.

9. Bartlam R, Mohanraj R. Ictal bradyarrhythmias and asystole requiring pacemaker implantation: Combined EEG-ECG analysis of 5 cases. Epilepsy Behav. 2016;64:212-5. doi:10.1016/j.yebeh.2016.06.026.

10. Desai R, Rupareliya C, Patel U, et al. Burden of Arrhythmias in Epilepsy Patients: A Nationwide Inpatient Analysis of 1.4 Million Hospitalizations in the United States. Cureus. 2017;9(8):e1550. doi:10.7759/cureus.1550.

11. Harden C, Tomson T, Gloss D, et al. Practice guideline summary: sudden unexpected death in epilepsy incidence rates and risk factors: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsy Curr. 2017;17(3):180-7. doi:10.5698/15357511.17.3.180.

12. Li J, Ming Q, Lin W. The insula lobe and sudden unexpected death in epilepsy: A hypothesis. Epileptic Disord. 2017;19(1):10-4. doi:10.1684/epd.2017.0890.

13. Nagai M, Hoshide S, Kario K. The insular cortex and cardiovascular system: A new insight into the brain-heart axis. J Am Soc Hypertens. 2010;4(4):174-82. doi:10.1016/j.jash.2010.05.001.

14. Mamalyga ML. Application of innovative technologies in the study of cerebral mechanisms of regulation of the cardiovascular system. Scientific and educational-methodical recommendations. M: Prometej. 2015 p. 9-11 (In Russ.)

15. Saetre E, Abdelnoor M, Amlie JP, et al. Cardiac function and antiepileptic drug treatment in the elderly: a comparison between lamotrigine and sustained-release carbamazepine. Epilepsia. 2009;50(8):1841-9. doi:10.1111/j.1528-1167.2009.02069.x.